A focused examination of the Gamma Knife Market Segment reveals a clear hierarchy of revenue streams based on clinical application, system type, and end-user setting. By Indication, the segment treating malignant tumors, overwhelmingly dominated by brain metastases, accounts for the largest revenue share. This is a high-volume, mandatory segment driven by the global oncology crisis and...